Efficacy, Dosage Concerns Unresolved On Sublingual Immunotherapy
Nov 7th 2008Drug InformationAllergies
Although sublingual immunotherapy (SLIT) is used in Europe and other countries, experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle say questions remain unanswered regarding its effectiveness, appropriate use, dosage, and safety of administration.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
